X

Neutra Corp. (NTRR) Develops New Products to Spur Innovation in Medical Marijuana Market

With demand for effective medical marijuana remedies growing by the day, indoor growers are changing the way doctors and patients think about the drug by breeding innovative, non-psychoactive strains. Neutra Corp. is developing new products to help deliver these greenhouse breakthroughs faster and easier than ever before.

Some of the most cutting-edge medical marijuana research is being done by growers in Colorado, where a young girl named Charlotte Figi made headlines recently after she became the youngest person in the state to be prescribed cannabis at age five.

Suffering from a rare, intractable form of epilepsy, Charlotte had 300 grand mal seizures a week. After trying barbituates and benzodiazepines, her parents turned to cannabis to save their daughter. Marijuana growers and dispensary owners the Stanley Brothers bred a strain with very little THC, cannabis’ psychoactive ingredient, but plenty of CBD, which has medicinal properties.

The effects were miraculous. Today, Charlotte’s seizures have been reduced to two or three per month, all without having to smoke marijuana or become high. The medicinal strain created for her, named Charlotte’s Web, is now being used by 41 other patients.

“This medical strain that won’t get you high is the future of medical marijuana,” said NTRR CEO Sydney Jim. “We’re developing new products for the marketplace that will make production of this incredible new medication faster, cleaner and safer than ever before, without the use of harsh chemicals or pesticides.”

For more information, visit www.neutracorp.com

Let us hear your thoughts: Neutra Corp. Message Board

Related Post